Tube in the bowel offers hope for stubborn constipation

NCT ID NCT07160192

Not yet recruiting Knowledge-focused Sponsor: Nantes University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study follows 80 adults who had a tube placed into their bowel (called a percutaneous endoscopic caecostomy, or PEC) to treat severe chronic constipation that didn't improve with standard treatments. Researchers will check long-term quality of life and how well the tube works by phone interviews and questionnaires. The goal is to see if this procedure is a safe and effective long-term solution.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: percutaneous endoscopic caecostomy (PEC) tube
What this could lead to: If successful, this could confirm that a PEC tube is a safe and effective long-term option for people with severe constipation that hasn't responded to other treatments.
What could go wrong: This is an observational study, not a controlled trial, so it cannot prove cause and effect. Results may be limited by the small number of participants (80) and the single-center design.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CONSTIPATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

constipation disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CONSTIPATION REFRACTORY

Contacts and locations

Locations

Nantes University Hospital

Nantes, Loire-Atlantique, 44093, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.